Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity

Adolescent Idiopathic Scoliosis Clinical Trial

Official title:

A Randomized Controlled Trial: Comparison of a Top Loading MESA® Spinal System With MESA Rail™ and a Side Locking Pedicle Screw System for the Treatment of Adolescent Paediatric Spine Deformity

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02590380
• Other study ID #: CAS-029
• Status: Withdrawn
• Phase: N/A
• Start date: September 2022
• Est. completion date: September 2030

Study information

• Verified date: October 2021
• Source: K2M, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system.

Description:

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. This is a single-center, single-surgeon randomized controlled trial with follow-up evaluations of patients conducted at initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure. Adverse events will be monitored continuously.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2030
• Est. primary completion date: September 2028
• Accepts healthy volunteers: No
• Gender: All
• Age group: 11 Years to 21 Years

Eligibility

Inclusion Criteria:

1. Diagnosis of Adolescent Idiopathic Scoliosis (AIS) with no associated syndrome requiring surgical treatment for selective thoracic/lumbar fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies. AIS cases must be classified as a Lenke type 1 or type 2 curve. No cervical vertebrae are to be incorporated into the construct.

2. Willingness and ability to comply with the requirements of the protocol including follow-up requirements.

3. Willing and able to sign a study specific informed consent form or, in the case of a patient who is a minor, provide assent and the minor patient's parent/legal guardian provides written consent to participate.

4. Age range of = 11 years old and = 21 years old at time of surgery.

Exclusion Criteria:

1. Previous anterior or posterior spine surgery at the index levels.

2. Previous posterior spine surgery (e.g., posterior element decompression) that destabilizes the cervical/thoracic/lumbar spine.

3. Active systemic infection or infection at the operative site.

4. Any sign of any spinal dysrhaphism (any cord abnormality).

5. Co-morbid medical conditions of the spine or upper/lower extremities that may affect the thoracic or lumbar spine neurological and/or pain assessment.

6. Metabolic bone disease such as osteoporosis that contradicts spinal surgery.

7. History of an osteoporotic fracture.

8. History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism.

9. Taking medications that may interfere with bony/soft tissue healing including chronic oral steroid use.

10. Known allergy to titanium or cobalt chrome.

11. Rheumatoid arthritis or other autoimmune disease or a systemic disorder such as HIV, active hepatitis B or C or fibromyalgia.

12. Insulin-dependent type 1 or type 2 diabetes.

13. Medical condition (e.g., unstable cardiac disease, cancer) that may result in patient death or have an effect on outcomes prior to study completion.

14. Pregnant, or intend to become pregnant, during the course of the study.

15. Severe obesity (Body Mass Index > 40).

16. Physical or mental condition (e.g., psychiatric disorder, senile dementia, Alzheimer's disease, alcohol or drug addiction) that would interfere with patient self-assessment of function, pain or quality of life.

17. Incarcerated at the time of study enrollment.

18. Current participation in an investigational study that may impact study outcomes.

Related Conditions & MeSH terms

• Adolescent Idiopathic Scoliosis
• Congenital Abnormalities
• Scoliosis

Intervention

Device:
• MESA Rail Deformity System
The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the MESA Rail Deformity System.
• DePuy Synthes USS II System
The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the DePuy Synthes USS II system.

Locations

Country	Name	City	State
United Kingdom	University Hospital Southampton	Southampton

Sponsors (1)

Lead Sponsor	Collaborator
K2M, Inc.

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Correction and Maintenance of Spinal Deformity (coronal)	Radiographic analysis of the spinal deformity in the coronal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.	Change from pre-operative to 3 months, 12 months and 24 months post-procedure
Primary	Correction and Maintenance of Spinal Deformity (sagittal)	Radiographic analysis of the spinal deformity in the sagittal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.	Change from pre-operative to 3 months, 12 months and 24 months post-procedure
Secondary	Back and Leg Pain 10cm Visual Analog Scale (VAS)	The severity of back and leg pain will be evaluated in all study subjects using a 10-cm visual analog scale (VAS). The study will employ a 15% improvement for success. OVERALL CHANGE from baseline will be assessed at each timepoint.	Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.
Secondary	SRS-22	Scoliosis and its treatment have a great impact on the quality of life of the affected patients. The Revised Scoliosis Research Society-22 (SRS-22r) is a specific questionnaire for spine conditions. It is applied to patients with idiopathic scoliosis, whose conditions and treatments have a great impact on their quality of life. The SRS-22r was created and revised with the purpose of evaluating this impact from the patient's point of view. The reviewed version contains 22 questions distributed into five domains: function/activity (FA), pain (P), self-image/appearance (SA), mental health (MH) and satisfaction with treatment (ST). The scores vary from 1 to 5, in which 5 is the best health quality of life of patients. OVERALL CHANGE from baseline will be assessed at each timepoint.	Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.
Secondary	Estimated Blood Volume Loss/Salvage Return	The amount of blood loss over the entire length of the surgery as well as salvage return volumes will be captured intraoperatively.	Operative Data - to be collected immediately after case is completed. Estimated blood loss will be noted by the surgical/anesthesia team and this value can then be immediately collected.
Secondary	Length of Hospital Stay	The length of hospital stay from the date of admission to the date of discharge will be calculated.	At discharge (up to one week post surgery) - Once the subject has been released from the hospital, the length of hospital stay can be calculated using the intake and discharge dates.
Secondary	Return to Work/School	The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery will be documented. Once the subject has returned to the "baseline" status this question will not be asked.	Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.
Secondary	Return to Sport/Physical Activity	The ability to return to sport as performed by the individual patient pre operatively. Time to walking unaided, running, swimming, trampoline, contact sport, normal social interactions with peer group. Once the subject has returned to the "baseline" status this question will not be asked.	Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.
Secondary	Use of Analgesia Post-Surgery	The types and dosages of any analgesia taken by the patient post-surgery will be documented. Overall change from baseline (pre-operative medications) will be analyzed at each interval - anticipation is that use of analgesia decreases and/or ends after surgery.	Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.